Health Care Companies Move for FTC Chair’s Recusal Over Past Comments
The FTC brought a complaint against pharmacy benefit managers for allegedly artificially inflating insulin prices. Major health care companies are calling on Federal Trade Commission (FTC) Chair Lina Khan and two of her fellow commissioners to recuse themselves from a case centering on how the companies price insulin. Pharmacy benefit managers (PBM) CVS Caremark, Cigna’s